SXTC: China SXT Pharmaceuticals, Inc. Kompaniya qiymatining sof foydaga nisbati

China SXT Pharmaceuticals, Inc. (SXTC) korporativ emblemasi va logotipi

China SXT Pharmaceuticals (SXTC) noyob xomashyo tozalash usullari va hukumat shartnomalaridan foydalangan holda, bo'lingan Osiyo bozorida raqobatlashmoqda. An'anaviy vositalarning sotuvidan tushadigan barqaror pul oqimi davriy tartibga soluvchi tekshiruvlarga qaramay moliyaviy barqarorlikni ta'minlaydi. 0.00 ko'rsatkichi bilan bog'liq tarixiy narxlar dinamikasi umumiy manzarani to'ldiradi, bunda rahbariyat ichki distributsiyaga va jarayonlarni modernizatsiya qilish davomida byurokratik to'siqlarni yengishga e'tibor qaratmoqda.

SXTC SXT Pharmaceuticals: Narx-foyda koeffitsiyenti 04.07.2022 - 16.11.2026 oraligʻida

SXT Pharmaceuticals (SXTC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:China SXT Pharmaceuticals, Inc. - SXTC
China SXT Pharmaceuticals, Inc. yetakchi tovari

China SXT Pharmaceuticals (SXTC) moliyaviy barqarorligini baholash bozor kapitalizatsiyasining sof foydaga nisbatini tahlil qilishni talab qiladi. Ushbu koeffitsient investitsiyalarning qoplanish muddatini belgilab, aktivning haddan tashqari qimmat yoki arzon baholanganini aniqlash imkonini beradi. Kompaniyaning P/E koeffitsiyenti o'zgarishlarini kuzatish orqali investor zarar ko'rish xatarlarini o'sish potentsiali bilan muvozanatga keltirishi mumkin. An'anaviy dori vositalari ishlab chiqaruvchisi bo'lgan ushbu kompaniya uchun mazkur ko'rsatkich sinalgan formulalarga bo'lgan konservativ talabni monetizatsiya qilishning samaradorligini tasdiqlaydi.

Muhim raqobatchilar

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - P/E multiplikatori|EPRX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BHST|EXOZ - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ORMP (oramed.com)|P/E multiplikatori enterabio.com ENTX|HYFT - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati ABVC BioPharma, Inc ABVC|CPIX: P/E multiplikatori|Quantum BioPharma Ltd - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti FGEN|Telomir Pharmaceuticals, Inc. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RANI|SNYR (Synergy CHC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning foydaga nisbati|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings PTHL|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)